|
1
|
Osanai M: Cellular retinoic acid
bioavailability in various pathologies and its therapeutic
implication. Pathol Int. 67:281–291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osanai M, Sawada N and Lee GH: Oncogenic
and cell survival properties of the retinoic acid metabolizing
enzyme, CYP26A1. Oncogene. 29:1135–1144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shelton DN, Sandoval IT, Eisinger A,
Chidester S, Ratnayake A, Ireland CM and Jones DA: Up-regulation of
CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a
WNT-dependent mechanism: Implications for intestinal cell
differentiation and colon tumor development. Cancer Res.
66:7571–7577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sonneveld E, van den Brink CE, van der
Leede BM, Schulkes RK, Petkovich M, van der Burg B and van der Saag
PT: Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly
specific for all-trans-RA and can be induced through RA receptors
in human breast and colon carcinoma cells. Cell Growth Differ.
9:629–637. 1998.PubMed/NCBI
|
|
5
|
Osanai M and Lee GH: Enhanced expression
of retinoic acid metabolizing enzyme CYP26A1 in sunlight-damaged
human skin. Med Mol Morphol. 44:200–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Osanai M and Lee GH: Increased expression
of the retinoic acid-metabolizing enzyme CYP26A1 during the
progression of cervical squamous neoplasia and head and neck
cancer. BMC Res Notes. 7:6972014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Osanai M and Lee GH: The retinoic
acid-metabolizing enzyme CYP26A1 upregulates fascin and promotes
the malignant behavior of breast carcinoma cells. Oncol Rep.
34:850–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolbach SB and Howe PR: Tissue changes
following deprivation of fat-soluble A vitamin. J Exp Med.
42:753–777. 1925. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abel EL, Angel JM, Kiguchi K and
DiGiovanni J: Multi-stage chemical carcinogenesis in mouse skin:
Fundamentals and applications. Nat Protoc. 4:1350–1362. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sundberg JP, Sundberg BA and Beamer WG:
Comparison of chemical carcinogen skin tumor induction efficacy in
inbred, mutant, and hybrid strains of mice: Morphologic variations
of induced tumors and absence of a papillomavirus cocarcinogen. Mol
Carcinog. 20:19–32. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
French AL, Kirstein LM, Massad LS, Semba
RD, Minkoff H, Landesman S, Palefsky J, Young M, Anastos K and
Cohen MH: Association of vitamin A deficiency with cervical
squamous intraepithelial lesions in human immunodeficiency
virus-infected women. J Infect Dis. 182:1084–1089. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Boudjelal M, Kang S, Voorhees JJ
and Fisher GJ: Ultraviolet irradiation of human skin causes
functional vitamin A deficiency, preventable by all-trans retinoic
acid pre-treatment. Nat Med. 5:418–422. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mohan R, Katiyar S, Khan S, Zaim M,
Mukhtar H and Agarwal R: Protective effect of all trans retinoic
acid against tumor promotion and progression in low- and high-risk
protocols of mouse skin chemical carcinogenesis. Int J Oncol.
8:1079–1088. 1996.PubMed/NCBI
|
|
15
|
Gressel KL, Duncan FJ, Oberyszyn TM, La
Perle KM and Everts HB: Endogenous retinoic acid required to
maintain the epidermis following ultraviolet light exposure in
SKH-1 hairless mice. Photochem Photobiol. 91:901–908. 2015.
View Article : Google Scholar : PubMed/NCBI
|
